Literature DB >> 11158333

Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.

K Tsujikawa1, N Kawakami, Y Uchino, T Ichijo, T Furukawa, H Saito, H Yamamoto.   

Abstract

Most receptor-like, transmembrane protein tyrosine phosphatases (PTPases), such as CD45 and the leukocyte common antigen-related (LAR) molecule, have two tandemly repeated PTPase domains in the cytoplasmic segment. The role of each PTPase domain in mediating PTPase activity remains unclear; however, it has been proposed that PTPase activity is associated with only the first of the two domains, PTPase domain 1, and the membrane-distal PTPase domain 2, which has no catalytic activity, would regulate substrate specificity. In this paper, we examine the function of each PTPase domain of LAR in vivo using a potential physiological substrate, namely insulin receptor, and LAR mutant proteins in which the conserved cysteine residue was changed to a serine residue in the active site of either or both PTPase domains. LAR associated with and preferentially dephosphorylated the insulin receptor that was tyrosine phosphorylated by insulin stimulation. Its association was mediated by PTPase domain 2, because the mutation of Cys-1813 to Ser in domain 2 resulted in weakening of the association. The Cys-1522 to Ser mutant protein, which is defective in the LAR PTPase domain 1 catalytic site, was tightly associated with tyrosine-phosphorylated insulin receptor, but failed to dephosphorylate it, indicating that LAR PTPase domain 1 is critical for dephosphorylation of tyrosine-phosphorylated insulin receptor. This hypothesis was further confirmed by using LAR mutants in which either PTPase domain 1 or domain 2 was deleted. Moreover, the association of the extracellular domains of both LAR and insulin receptor was supported by using the LAR mutant protein without the two PTPase domains. LAR was phosphorylated by insulin receptor tyrosine kinase and autodephosphorylated by the catalytic activity of the PTPase domain 1. These results indicate that each domain of LAR plays distinct functional roles through phosphorylation and dephosphorylation in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158333     DOI: 10.1210/mend.15.2.0592

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  Identification of novel, less toxic PTP-LAR inhibitors using in silico strategies: pharmacophore modeling, SADMET-based virtual screening and docking.

Authors:  Dara Ajay; M Elizabeth Sobhia
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

2.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

3.  RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain.

Authors:  Yutao Wen; Shen Yang; Kuninobu Wakabayashi; Mattias N D Svensson; Stephanie M Stanford; Eugenio Santelli; Nunzio Bottini
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

4.  Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.

Authors:  Daniel Fisher; Bin Xing; John Dill; Hui Li; Hai Hiep Hoang; Zhenze Zhao; Xiao-Li Yang; Robert Bachoo; Stephen Cannon; Frank M Longo; Morgan Sheng; Jerry Silver; Shuxin Li
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

5.  Leukocyte antigen-related protein tyrosine phosphatase negatively regulates hydrogen peroxide-induced vascular smooth muscle cell apoptosis.

Authors:  Juxiang Li; Xi-Lin Niu; Nageswara R Madamanchi
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

6.  High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.

Authors:  George T Lountos; Sreejith Raran-Kurussi; Bryan M Zhao; Beverly K Dyas; Terrence R Burke; Robert G Ulrich; David S Waugh
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

7.  Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas.

Authors:  N Konishi; K Tsujikawa; H Yamamoto; E Ishida; M Nakamura; K Shimada; K Yane; H Yamashita; S Noguchi
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

8.  Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling.

Authors:  John O DaSilva; George P Amorino; Eli V Casarez; Bradley Pemberton; Sarah J Parsons
Journal:  Prostate       Date:  2012-11-28       Impact factor: 4.104

9.  Lar maintains the homeostasis of the hematopoietic organ in Drosophila by regulating insulin signaling in the niche.

Authors:  Harleen Kaur; Shiv Kumar Sharma; Sudip Mandal; Lolitika Mandal
Journal:  Development       Date:  2019-12-23       Impact factor: 6.868

10.  The allelic variant of LAR gene promoter -127 bp T-->A is associated with reduced risk of obesity and other features related to insulin resistance.

Authors:  Giuseppe Miscio; Vittorio Tassi; Angelo Coco; Teresa Soccio; Rosa Di Paola; Sabrina Prudente; Roberto Baratta; Lucia Frittitta; Ornella Ludovico; Libera Padovano; Bruno Dallapiccola; Umberto Di Mario; Salvatore De Cosmo; Vincenzo Trischitta
Journal:  J Mol Med (Berl)       Date:  2004-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.